natgillin/translations-raw huggingface dataset:
A mathematical predictive method has been developed at the Technological University of Denmark, to determine which level of benzoic acid benzoate (E 210-213) is needed [3].
Na tehnološkom sveučilištu Danske razvijena je matematička metoda predviđanja za utvrđivanje potrebne razine benzojeve kiseline – benzoata (E 210–213) [3].
According to that model the level of 1000 mg/kg of E 210-213 is not sufficient to prevent growth of Listeria monocytogenes in shrimps in brine at pH 5,8.
Prema tom modelu razina od 1000 mg/kg E 210–213 nije dovoljna za sprečavanje rasta bakterije Listeria monocytogene u kozicama u salamuri pH vrijendosti 5,8.
In order to prevent growth of Listeria monocytogenes in these shrimps, both the model and tests show that the optimal combination of benzoic acid — benzoates (E 210-213) and sorbic acid — sorbates (E 200-203) is 1500 mg/kg and 500 mg/kg respectively.
Model i ispitivanja upućuju na to da je za sprečavanje rasta bakterije Listeria monocytogene u tim kozicama optimalna kombinacija 1500 mg/kg benzojeve kiseline – benzoata (E 210–213) te 500 mg/kg sorbinske kiseline – sorbata (E 200–203).
In its report trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2012 [4], the European Food Safety Authority (the Authority) concluded that the number of listeriosis cases in humans increased slightly compared with 2011, and 1642 confirmed human cases were reported in 2012.
U svojem izvješću o kretanjima i izvorima zoonoza, uzročnika zoonoza i bolesti koje se prenose hranom u 2012. [4], Europska agencija za sigurnost hrane („Agencija”) zaključila je da se broj slučajeva listerioze kod ljudi neznatno povećao u usporedbi s 2011. te su 2012. prijavljene 1642 potvrđene pojave kod ljudi.
A statistically significant increasing trend in the Union was observed over the period 2008-2012, though only slowly increasing, along with a seasonal pattern.
Tijekom razdoblja od 2008. do 2012. zabilježen je statistički značajan rast u Uniji koji se tek polako povećavao prateći sezonski uzorak.
As in previous years, a high fatality rate (17,8 %) was reported among the cases.
Kao i prethodnih godina, među tim slučajevima je zabilježena visoka stopa smrtnosti (17,8 %).
A total of 198 deaths due to listeriosis were reported by 18 Member States in 2012, which was the highest number of fatal cases reported since 2006.
2012. godine18 država članica prijavilo je ukupno 198 smrtnih slučajeva zbog listerioze što je najveći broj smrtnih slučajeva zabilježen od 2006.
Listeria monocytogenes was seldomly detected above the legal safety limit for ready-to-eat foods at point of retail.
Bakterija Listeria monocytogenes rijetko je utvrđena iznad zakonitog sigurnosnog ograničenja za gotovu hranu na mjestu maloprodaje.
Samples exceeding this limit were most often found in fishery products.
Uzorci koji premašuju to ograničenje najčešće su uzeti iz proizvoda ribarstva.
The Commission report on Dietary Food Additive Intake in the European Union [5] concluded that exposure to benzoic acid — benzoates could be up to 96 % of the ADI for young children and 84 % for adults based on the use at maximum permitted levels.
U Izvješću Komisije o unosu prehrambenih aditiva u Europskoj uniji [5] zaključeno je da izloženost benzojevoj kiselini – benzoatima može iznositi do 96 % prihvatljivog dnevnog unosa za malu djecu i 84 % za odrasle osobe na temelju uporabe najvećih dopuštenih razina.
At that time a maximum level in cooked shrimps of 2000 mg/kg was set for sorbic acid — sorbates in combination with benzoic acid — benzoates.
Tada je najveća dopuštena razina sorbinske kiseline – sorbata u kombinaciji s benzojevom kiselinom – benzoatima u kuhanim kozicama iznosila 2000 mg/kg.
This level was revised by Directive 2006/52/EC of the European Parliament and of the Council [6] when this authorisation was extended to all cooked crustaceans and molluscs, however with a maximum of 1000 mg/kg for benzoic acid — benzoates.
Ta je razina izmijenjena Direktivom 2006/52/EZ Europskog parlamenta i Vijeća [6] kada je to odobrenje prošireno na sve kuhane rakove i mekušce, s najvećom dopuštenom razinom od 1000 mg/kg za benzojevu kiselinu – benzoate.
It is therefore expected that the increase of this level to 1500 mg/kg, only for cooked shrimps in brine, will not lead to additional exposure that would be of safety concern.
Stoga se očekuje da povećanje te razine na 1500 mg/kg, samo za kuhane kozice u salamuri, neće dovesti do dodatne izloženosti koja bi mogla biti sigurnosni rizik.
Pursuant to Article 3(2) of Regulation (EC) No 1331/2008, the Commission is to seek the opinion of the Authority in order to update the Union list of food additives set out in Annex II to Regulation (EC) No 1333/2008, except where the update in question is not liable to have an effect on human health.
U skladu s člankom 3. stavkom 2. Uredbe (EZ) br. 1331/2008 Komisija je dužna zatražiti mišljenje Agencije kako bi ažurirala popis prehrambenih aditiva Unije iz Priloga II. Uredbi (EZ) br. 1333/2008, osim ako postoji mogućnost da se takvim ažuriranjem ne utječe na zdravlje ljudi.
Since the authorisation of the use of benzoic acid — benzoates (E 210-213) in cooked shrimps preserved in brine constitutes an update of that list which is not liable to have an effect on human health, it is not necessary to seek the opinion of the Authority.
Budući da se odobrenje uporabe benzojeve kiseline – benzoata (E 210–213) u kuhanim kozicama konzerzviranima u salamuri smatra ažuriranjima tog popisa koje neće imati utjecaj na zdravlje ljudi, nije potrebno tražiti mišljenje Agencije.
Therefore, Annex II to Regulation (EC) No 1333/2008 should be amended accordingly.
Prilog II. Uredbi (EZ) br. 1333/2008 stoga treba na odgovarajući način izmijeniti.
Annex II to Regulation (EC) No 1333/2008 is amended in accordance with the Annex to this Regulation.
Prilog II. Uredbi (EZ) br. 1333/2008 izmjenjuje se u skladu s Prilogom ovoj Uredbi.
It shall apply from the date of entry into force of this Regulation.
Primjenjuje se od trenutka stupanja na snagu ove Uredbe.
Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings (OJ L 354, 31.12.2008, p. 1).
Uredba (EZ) br. 1331/2008 Europskog parlamenta i Vijeća od 16. prosinca 2008. o uspostavi zajedničkog postupka odobravanja prehrambenih aditiva, prehrambenih enzima i prehrambenih aroma (SL L 354, 31.12.2008., str. 1.).
The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2012, (EFSA Journal 2014;12(2):3547), http://www.efsa.europa.eu/en/efsajournal/doc/3547.pdf
Sažeto izvješće Europske unije o kretanjima i izvorima zoonoza, uzročnika zoonoza i bolesti koje se prenose hranom u 2012., (EFSA Journal 2014;12(2):3547), http://www.efsa.europa.eu/en/efsajournal/doc/3547.pdf
COM(2001) 542 final.
COM(2001) 542 završna verzija.
Directive 2006/52/EC of the European Parliament and of the Council of 5 July 2006 amending Directive 95/2/EC on food additives other than colours and sweeteners and Directive 94/35/EC on sweeteners for use in foodstuffs (OJ L 204, 26.7.2006, p. 10).
Direktiva 2006/52/EZ Europskog parlamenta i Vijeća od 5. srpnja 2006. o izmjeni Direktive 95/2/EZ o prehrambenim aditivima osim bojila i sladila te Direktive 94/35/EZ o sladilima za upotrebu u hrani (SL L 204, 26.7.2006., str. 10.).
In Part E of Annex II to Regulation (EC) No 1333/2008, in the food category 09.2 'Processed fish and fishery products including molluscs and crustaceans', the following entry is added after the entry for food additive E 210-213:
U dijelu E Priloga II. Uredbi (EZ) br. 1333/2008 u kategoriji hrane 09.2. „Prerađena riba i proizvodi ribarstva uključujući školjke i rakove” nakon unosa za prehrambeni aditiv E 210–213 dodaje se sljedeći unos:
Benzoic acid — benzoates
Benzojeva kiselina – benzoati
Only cooked shrimps in brine’
Samo kuhane kozice u salamuri”
Commission Regulation (EU) 2015/539
Uredba Komisije (EU) 2015/539
Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods [1], and in particular Articles 18(4) and 19 thereof,
uzimajući u obzir Uredbu (EZ) br. 1924/2006 Europskog parlamenta i Vijeća od 20. prosinca 2006. o prehrambenim i zdravstvenim tvrdnjama koje se navode na hrani [1], a posebno njezin članak 18. stavak 4. i članak 19.,
Pursuant to Article 13(3) of Regulation (EC) No 1924/2006, Commission Regulation (EU) No 432/2012 [2] was adopted, which establishes a list of permitted health claims made on foods other than those referring to the reduction of disease risk and to children's development and health.
U skladu s člankom 13. stavkom 3. Uredbe (EZ) br. 1924/2006 donesena je Uredba Komisije (EU) br. 432/2012 [2], kojom je utvrđen popis dopuštenih zdravstvenih tvrdnji koje se navode na hrani, osim onih koje se odnose na smanjenje rizika od bolesti te na razvoj i zdravlje djece.
Regulation (EC) No 1924/2006 provides that applications for authorisations of health claims are to be submitted by food business operators to the national competent authority of a Member State.
Uredbom (EZ) br. 1924/2006 predviđa se da subjekti u poslovanju s hranom podnose zahtjeve za odobrenje zdravstvenih tvrdnji nacionalnom nadležnom tijelu države članice.
The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’, for a scientific assessment, as well as to the Commission and the Member States for information.
Nacionalno nadležno tijelo prosljeđuje valjane zahtjeve na znanstvenu ocjenu Europskoj agenciji za sigurnost hrane (EFSA), dalje u tekstu: „Agencija”, te Komisiji i državama članicama za informaciju.
In order to stimulate innovation, health claims which are based on newly developed scientific evidence and/or which include a request for the protection of proprietary data shall undergo an accelerated type of authorisation.
Kako bi se potakle inovacije, zdravstvene tvrdnje koje su utemeljene na novim znanstvenim dokazima i/ili uključuju zahtjev za zaštitu vlasničkih podataka podliježu ubrzanom načinu odobravanja.
Following an application from Barry Callebaut Belgium NV submitted pursuant to Article 19(1) of Regulation (EC) No 1924/2006 and including a request for protection of proprietary data, the Authority was required to deliver an opinion on the modification of the authorisation of health claim ‘cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow’.
Na temelju zahtjeva subjekta Barry Callebaut Belgium NV, koji je podnesen u skladu s člankom 19. stavkom 1. Uredbe (EZ) br. 1924/2006 i u kojem je uključen zahtjev za zaštitu vlasničkih podataka, Agencija je trebala dostaviti mišljenje o izmjeni odobrenja zdravstvene tvrdnje „Kakao koji sadržava flavanol pomaže u očuvanju elastičnosti krvnih žila, što pridonosi normalnom protoku krvi”.
That health claim was authorised, pursuant to Article 13(5) of Regulation (EC) No 1924/2006, by Commission Regulation (EU) No 851/2013 [3].
Ta je zdravstvena tvrdnja odobrena Uredbom Komisije (EU) br. 851/2013 [3] u skladu s člankom 13. stavkom 5. Uredbe (EZ) br. 1924/2006.
The applicant requested an extension of the authorised conditions of use of the claim to a high-flavanols (HF) cocoa extract to be consumed in capsules, tablets or added to ‘other foods, including beverages’.
Podnositelj zahtjeva zatražio je proširenje odobrenih uvjeta za uporabu tvrdnje na ekstrakt kakaa s visokim sadržajem flavanola (HF) koji se konzumira u obliku kapsula, tableta ili je dodan „drugoj hrani, uključujući pića”.
On 5 May 2014, the Commission and the Member States received a scientific opinion from the Authority (Question No EFSA-Q-2013-00832) [4] which concluded that on the basis of the data submitted, a cause and effect relationship had been established between the consumption of cocoa flavanols in the HF cocoa extract (i.e. in capsules or tablets) and the claimed effect.
Komisija i države članice primile su 5. svibnja 2014. znanstveno mišljenje Agencije (pitanje br. EFSA-Q-2013-00832) [4] u kojem je zaključeno da je na temelju dostavljenih podataka utvrđeno postojanje uzročno-posljedične veze između konzumacije flavanola iz ekstrakta kakaa s visokim sadržajem flavanola (u obliku kapsula ili tableta) i navedenog učinka.
The Authority indicated in its opinion that its conclusions could not have been reached without considering one human intervention study claimed by the applicant as proprietary. [5]
Agencija je u svojem mišljenju navela da zaključci ne bi mogli biti doneseni bez uzimanja u obzir jedne intervencijske studije provedene na ljudima za koju podnositelj zahtjeva traži zaštitu vlasničkih prava [5].
All the justifiable information provided by the applicant has been assessed by the Commission and it is considered that the requirements laid down in Article 21(1) of Regulation (EC) No 1924/2006 are fulfilled for the study claimed as proprietary.
Komisija je ocijenila sve valjane podatke koje je dostavio podnositelj zahtjeva i smatra se da su zahtjevi utvrđeni člankom 21. stavkom 1. Uredbe (EZ) br. 1924/2006 ispunjeni u studiji za koju se traži zaštita vlasničkih prava.
Accordingly, the scientific data and other information included in that study may not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation, under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.
U skladu s tim znanstveni podaci i ostale informacije iz navedene studije ne smiju se upotrijebiti u korist drugih podnositelja zahtjeva u razdoblju od pet godina od datuma stupanja na snagu ove Uredbe, u skladu s uvjetima utvrđenima u članku 21. stavku 1. Uredbe (EZ) br. 1924/2006.
One of the objectives of Regulation (EC) No 1924/2006 is to ensure that health claims are truthful, clear and reliable and useful to the consumer, and that the wording and the presentation are taken into account in that respect.
Jedan od ciljeva Uredbe (EZ) br. 1924/2006 jest osigurati da zdravstvene tvrdnje budu istinite, jasne, pouzdane i korisne potrošaču te da se u tom smislu treba uzeti u obzir tekst i predstavljanje tih tvrdnji.
Therefore, where the wording of claims used by the applicant has the same meaning for consumers as that of an authorised health claim, because they demonstrate the same relationship that exists between a food category, a food or one of its constituents and health, they should be subject to the same conditions of use as those listed in the Annex to this Regulation.
Stoga, ako tekst nekih tvrdnji koje je sastavio podnositelj zahtjeva ima za potrošače isto značenje kao tekst odobrene zdravstvene tvrdnje jer upućuje na isti odnos između određene kategorije hrane, određene hrane ili jednog od njezinih sastojaka i zdravlja, za dotične tvrdnje trebaju vrijediti isti uvjeti uporabe kao uvjeti koji su navedeni u Prilogu ovoj Uredbi.
In accordance with Article 20 of Regulation (EC) No 1924/2006, the Register of nutrition and health claims containing all authorised health claims should be updated in order to take into account this Regulation.
U skladu s člankom 20. Uredbe (EZ) br. 1924/2006, registar s prehrambenim i zdravstvenim tvrdnjama koji sadržava sve odobrene zdravstvene tvrdnje treba se ažurirati kako bi se uzelo u obzir ovu Uredbu.
Since the applicant claims protection of proprietary data, it is considered appropriate to restrict the use of this claim in favour of the applicant for a period of five years.
Budući da podnositelj zahtjeva traži zaštitu vlasničkih podataka, smatra se primjerenim ograničiti uporabu te tvrdnje u korist podnositelja zahtjeva na razdoblje od pet godina.
However, the authorisation of this claim restricted for the use of an individual operator should not prevent other applicants from applying for authorisation to use the same claim in case the application is based on data and studies other than those protected under Article 21 of Regulation (EC) No 1924/2006.
Međutim, odobravanje te tvrdnje ograničeno na uporabu pojedinih subjekata ne sprječava druge podnositelje zahtjeva da zatraže odobravanje iste tvrdnje ako je zahtjev temeljen na podacima i studijama, osim onih zaštićenih u skladu s člankom 21. Uredbe (EZ) br. 1924/2006.
The comments from the applicant received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.
Pri određivanju mjera predviđenih ovom Uredbom Komisija je uzela u obzir primjedbe koje joj je dostavio podnositelj zahtjeva u skladu s člankom 16. stavkom 6. Uredbe (EZ) br. 1924/2006.
Regulation (EU) No 432/2012 should therefore be amended accordingly.
Uredbu (EU) br. 432/2012 treba stoga na odgovarajući način izmijeniti.
The health claim set out in the Annex to this Regulation shall be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Zdravstvena tvrdnja navedena u Prilogu ovoj Uredbi uvrštava se u popis dopuštenih tvrdnji Unije kako je predviđeno člankom 13. stavkom 3. Uredbe (EZ) br. 1924/2006.
The use of the health claim referred to in the first paragraph shall be restricted to the applicant for a period of five years from the date of entry into force of this Regulation.
Uporaba zdravstvene tvrdnje iz prvog stavka ograničava se na podnositelja zahtjeva na razdoblje od pet godina od dana stupanja na snagu ove Uredbe.
After the expiry of that period, that health claim may be used, in conformity with the conditions applying to it, by any food business operator.
Nakon isteka tog razdoblja svaki subjekt u poslovanju hranom može upotrebljavati navedenu zdravstvenu tvrdnju u skladu s uvjetima koji se na nju primjenjuju.
The scientific data and other information included in the application, which are claimed by the applicant as proprietary and without the submission of which the health claim could not have been authorised are restricted for use for the benefit of the applicant for a period of five years from the date of entry into force of this Regulation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.
Znanstveni podaci i druge informacije u zahtjevu za koje podnositelj zahtjeva traži zaštitu vlasničkih prava i bez kojih zdravstvena tvrdnja ne bi bila odobrena, ograničeni su na uporabu u korist podnositelja zahtjeva na razdoblje od pet godina od datuma stupanja na snagu ove Uredbe u skladu s uvjetima utvrđenima člankom 21. stavkom 1. Uredbe (EZ) br. 1924/2006.
Commission Regulation (EU) No 851/2013 of 3 September 2013 authorising certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health and amending Regulation (EU) No 432/2012 (OJ L 235, 4.9.2013, p. 3).
Uredba Komisije (EU) br. 851/2013 оd 3. rujna 2013. o odobravanju određenih zdravstvenih tvrdnji koje se navode na hrani, osim onih koje se odnose na smanjenje rizika od bolesti te na razvoj i zdravlje djece i o izmjeni Uredbe (EU) br. 432/2012 (SL L 235, 4.9.2013., str. 3.).
In the Annex to Regulation (EU) No 432/2012, the entry for cocoa flavanols is replaced by the following:
Unos za kakao koji sadržava flavanol u Prilogu Uredbi (EU) br. 432/2012 zamjenjuje se sljedećim unosom:
Conditions of use of the claim
Uvjeti korištenja tvrdnje
Conditions and/or restrictions of use of the food and/or additional statement or warning
Uvjeti i/ili ograničenja korištenja hrane i/ili dodatna izjava ili upozorenje
‘Cocoa flavanols
„Flavanoli iz kakaa
Cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow [1] [2]
Flavanoli iz kakaa pomažu u očuvanju elastičnosti krvnih žila, što pridonosi normalnom protoku krvi [1] [2]
Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 200 mg of cocoa flavanols.
Potrošaču se daju informacije da se povoljan učinak postiže dnevnim unosom od 200 mg flavanola iz kakaa.
The claim can be used only for cocoa beverages (with cocoa powder) or for dark chocolate which provide at least a daily intake of 200 mg of cocoa flavanols with a degree of polymerisation 1-10. [1]The claim can be used only for capsules or tablets containing high-flavanol cocoa extract which provide at least a daily intake of 200 mg of cocoa flavanols with a degree of polymerisation 1-10. [2]
Tvrdnja se smije koristiti samo za napitke od kakaa (s kakaom u prahu) ili za tamnu čokoladu koji u dnevnom unosu pružaju barem 200 mg flavanola iz kakaa sa stupnjem polimerizacije 1-10 [1]Tvrdnja se smije koristiti samo za kapsule ili tablete koje sadržavaju ekstrakt kakaa s visokim sadržajem flavanola koji u dnevnom unosu pružaju barem 200 mg flavanola iz kakaa sa stupnjem polimerizacije 1-10 [2]
Authorised on 24 September 2013 restricted to the use of Barry Callebaut Belgium NV, Aalstersestraat 122, B-9280 Lebbeke-Wieze, Belgium, for a period of five years.
Odobreno na dan 24. rujna 2013. pravo korištenja ograničeno je na Barry Callebaut Belgium NV, Aalstersestraat 122, B-9280 Lebbeke-Wieze, Belgija, na razdoblje od pet godina.
Authorised on 21 April 2015 restricted to the use of Barry Callebaut Belgium NV, Aalstersestraat 122, B-9280 Lebbeke-Wieze, Belgium, for a period of five years.’
Odobreno na dan 21. travnja 2015. pravo korištenja ograničeno je na Barry Callebaut Belgium NV, Aalstersestraat 122, B-9280 Lebbeke-Wieze, Belgija, na razdoblje od pet godina.”
Pharmacokinetic study to assess the bioavailability of the cocoa flavanol epicatechin from different matrices.
Farmakokinetička studija za procjenu biološke raspoloživosti epikatekina kakaovih flavanola u različitim matricama.
Commission Implementing Regulation (EU) 2015/540
Provedbena uredba Komisije (EU) 2015/540
Commission Implementing Regulation (EU) 2015/543
Provedbena uredba Komisije (EU) 2015/543
approving the active substance COS-OGA, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobravanju aktivne tvari COS-OGA u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja i o izmjeni Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 22(1) in conjunction with Article 13(2) thereof,
uzimajući u obzir Uredbu (EZ) br. 1107/2009 Europskog parlamenta i Vijeća od 21. listopada 2009. o stavljanju na tržište sredstava za zaštitu bilja i stavljanju izvan snage direktiva Vijeća 79/117/EEZ i 91/414/EEZ [1], a posebno njezin članak 22. stavak 1. u vezi s njezinim člankom 13. stavkom 2.,
In accordance with Article 7(1) of Regulation (EC) No 1107/2009, Belgium received on 28 June 2012 an application from FytoFend SA for the approval of the active substance COS-OGA.
U skladu s člankom 7. stavkom 1. Uredbe (EZ) br. 1107/2009 Belgija je 28. lipnja 2012. primila zahtjev od subjekta FytoFend SA za odobrenje aktivne tvari COS-OGA.
In accordance with Article 9(3) of that Regulation, Belgium, as rapporteur Member State, notified the Commission on 5 December 2012 of the admissibility of the application.
U skladu s člankom 9. stavkom 3. te Uredbe, Belgija je, kao država članica izvjestiteljica, 5. prosinca 2012. obavijestila Komisiju o prihvatljivosti zahtjeva.